BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 4771904)

  • 1. Differential study of 2 long-acting neuroleptics, fluphenazine enanthate and pipothiazine undecylenate.
    Gayral LF; Escande MM; Fournie HC; Huron RJ
    Therapie; 1973; 28(3):611-25. PubMed ID: 4771904
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate].
    Angst J; Woggon B
    Arzneimittelforschung; 1975 Feb; 25(2):267-70. PubMed ID: 1091272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prolonged action neuroleptics (review of the foreign literature)].
    Obukhov GA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(2):285-95. PubMed ID: 235182
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study of delayed-action neuroleptics in psychiatric therapeutics].
    Pellet J; Guyotat J; Marie-Cardine M; Dubor P; Favre-Tissot M; Caron F; Cottraux J
    J Med Lyon; 1972 Apr; 53(227):591-8. PubMed ID: 4404295
    [No Abstract]   [Full Text] [Related]  

  • 5. [Trial of delayed-action neuroleptics in the treatment of acute psychotic conditions].
    Gayral L; Escande M; Fournié H; Perretti A
    Ann Med Psychol (Paris); 1972 Mar; 1(3):381-94. PubMed ID: 5053751
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluspirilene and pipothiazine undecylenate, two long-acting injectable neuroleptics. A double-blind controlled trial in residual schizophrenia.
    Vereecken JL; Tanghe A
    Psychiatr Neurol Neurochir; 1972; 75(2):117-27. PubMed ID: 5030483
    [No Abstract]   [Full Text] [Related]  

  • 7. [Importance of delayed-action compounds for management of neuroleptic treatments. (Apropos of fluphenazine enanthate)].
    Delay J; Deniker P; Perier M; Dalle B
    Presse Med (1893); 1967 May; 75(24):1243-6. PubMed ID: 6024177
    [No Abstract]   [Full Text] [Related]  

  • 8. [Differential indication for the use of neuroleptics].
    Vinar O
    Act Nerv Super (Praha); 1970 Jan; 12(1):1-11. PubMed ID: 4907389
    [No Abstract]   [Full Text] [Related]  

  • 9. The depot compounds moditen (fluphenazine) and IMAP (fluspirilene) in clinical practice.
    Faltus F
    Act Nerv Super (Praha); 1974 Aug; 16(3):167-8. PubMed ID: 4607824
    [No Abstract]   [Full Text] [Related]  

  • 10. [Importance of delayed-action neuroleptics].
    Fouks ; Houssait ; Mathis ; Gay M; Ferragu ; Gilbert
    Ann Med Psychol (Paris); 1969 May; 1(5):772-8. PubMed ID: 5398062
    [No Abstract]   [Full Text] [Related]  

  • 11. [Importance of delayed-action neuroleptics].
    Fouks ; Houssait ; Mathis ; Gay M; Ferragu ; Gilbert
    Ann Med Psychol (Paris); 1969 May; 127(5):772-8. PubMed ID: 5397523
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-acting neuroleptic preparations and their use in mental disorders].
    Vovin RIa; Vovina EN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(6):920-4. PubMed ID: 5050052
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical and ambulatory experiences with fluphenazine decanoate lyogen depot in prolonged therapy of psychiatric disorders].
    Moldenhauer B
    Med Welt; 1970 Jun; 25():1150-4. PubMed ID: 5512636
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of new drug treatments in child psychiatry (long-acting neuroleptics, antidepressive agents and lithium)].
    Dugas M; Velin J; Guériot C; Frohwirth C
    Cah Med; 1973 Sep; 14(9):711-6. PubMed ID: 4779496
    [No Abstract]   [Full Text] [Related]  

  • 15. A multicenter controlled trial of fluspirilene and fluphenazine enanthate in chronic schizophrenic syndromes.
    Malm U; Perris C; Rapp W; Wedrén G
    Acta Psychiatr Scand Suppl; 1974; 249():94-116. PubMed ID: 4608506
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychiatric pharmacotherapy and the schizophrenic defect.
    Molcan J; Floreánová L; Novotný V; Polák L; Rakús A; Motýlová A
    Act Nerv Super (Praha); 1973 May; 15(2):91. PubMed ID: 4148088
    [No Abstract]   [Full Text] [Related]  

  • 17. [Long-action neuroleptic agents (delayed-action neuroleptics)].
    Ginestet D; Péron-Magnan P
    Rev Prat; 1972 Apr; 22(12):1941-53. PubMed ID: 4675045
    [No Abstract]   [Full Text] [Related]  

  • 18. [Considerations on the use of long-acting neuroleptics in a mental health center].
    Carotti P; Merli R
    Minerva Med; 1986 Sep; 77(34-35):1577-83. PubMed ID: 2876402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Initial results of clinical trial of a new long-acting neuroleptic agent: Fluspirelene].
    Ciccarelli G; Nosè F
    Minerva Med; 1971 Dec; 62(98):4922-7. PubMed ID: 5141918
    [No Abstract]   [Full Text] [Related]  

  • 20. Differences in clinical effects of three phenothiazines in "acute" schizophrenia.
    Dis Nerv Syst; 1967 Jun; 28(6):369-83. PubMed ID: 5342391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.